Medicenna Therapeutics (MDNA) PT Lowered to $7 at Maxim Group
Tweet
Share
E-mailGet Alerts MDNA Hot Sheet
Price: $0.16 --0%
Rating Summary:
1 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 10 | Down: 6 | New: 33
Rating Summary:
1 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 10 | Down: 6 | New: 33
Join SI Premium – FREE
Maxim Group analyst Naureen Quibria lowered the price target on Medicenna Therapeutics (NASDAQ: MDNA) to $7.00 (from $9.00) while maintaining a Buy rating.
You May Also Be Interested In
- Designer Brands (DBI) PT Lowered to $6 at UBS
- Kepler Cheuvreux Upgrades Entain PLC (ENT:LN) (GMVHF) to Buy
- NIO Inc (9866:HK) (NIO) PT Lowered to HK$54.40 at Citi
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
